# Evaluation of Chitosan Scaffold and Mineral Trioxide Aggregate Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis

> **NCT04308863** · PHASE2 · COMPLETED · sponsor: **Nourhan M.Aly** · enrollment: 30 (actual)

## Conditions studied

- Pulpitis - Irreversible

## Interventions

- **DRUG:** Chitosan scaffold/ MTA pulp dressing material
- **DRUG:** MTA pulp dressing material

## Key facts

- **NCT ID:** NCT04308863
- **Lead sponsor:** Nourhan M.Aly
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-15
- **Primary completion:** 2020-10-30
- **Final completion:** 2020-12-20
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-05-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04308863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04308863, "Evaluation of Chitosan Scaffold and Mineral Trioxide Aggregate Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04308863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*